Publication:
Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting

dc.contributor.authorsSancar, M.; Akyildiz, E.; Okuyan, B.; Rabus, S. Apikoglu; Carli, B. Soydeger; Yilmaz, Z.; Izzettin, F. V.
dc.date.accessioned2022-03-10T17:50:26Z
dc.date.accessioned2026-01-10T18:57:34Z
dc.date.available2022-03-10T17:50:26Z
dc.date.issued2011
dc.identifier.doidoiWOS:000289415500348
dc.identifier.issn2210-7703
dc.identifier.urihttps://hdl.handle.net/11424/221339
dc.identifier.wosWOS:000289415500348
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCardiovascular
dc.subjectHyperlipidemia
dc.subjectPharmacy
dc.subjectRisk assesment
dc.titleCardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage430
oaire.citation.issue2
oaire.citation.startPage429
oaire.citation.titleINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
oaire.citation.volume33

Files